Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
Cancer Research|July 2, 2016
Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic FactorsFang Li, Xinjian Liu, John H Sampson, et al.
Nuclear Medicine and Biology|September 28, 2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligandsMarc Hens, Ganesan Vaidyanathan, Xiao-Guang Zhao, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Central nervous systemD Cory Adamson, B Ahmed K Rasheed, Roger E McLendon, et al.
Nuclear Medicine and Biology|February 20, 2007
Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligandsAlexander T Yordanov, Marc Hens, Charles Pegram, et al.
Journal of Neurosurgery|April 16, 2013
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a reviewTiffany R Hodges, Bryan D Choi, Darell D Bigner, et al.
Nuclear Medicine and Biology|October 9, 2007
Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodiesMichael R Zalutsky, David A Reardon, Oscar R Pozzi, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2009
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cellsMeryem Bektas, Stewart P Johnson, William E Poe, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Plos One|May 5, 2012
Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cellsMatthew Wortham, Genglin Jin, Julia Lailai Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2011
Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumorsStephen T Keir, Mark W Dewhirst, John P Kirkpatrick, et al.
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
Cancer Research|July 2, 2016
Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic FactorsFang Li, Xinjian Liu, John H Sampson, et al.
Nuclear Medicine and Biology|September 28, 2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligandsMarc Hens, Ganesan Vaidyanathan, Xiao-Guang Zhao, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Central nervous systemD Cory Adamson, B Ahmed K Rasheed, Roger E McLendon, et al.
Nuclear Medicine and Biology|February 20, 2007
Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligandsAlexander T Yordanov, Marc Hens, Charles Pegram, et al.
Journal of Neurosurgery|April 16, 2013
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a reviewTiffany R Hodges, Bryan D Choi, Darell D Bigner, et al.
Nuclear Medicine and Biology|October 9, 2007
Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodiesMichael R Zalutsky, David A Reardon, Oscar R Pozzi, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2009
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cellsMeryem Bektas, Stewart P Johnson, William E Poe, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Plos One|May 5, 2012
Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cellsMatthew Wortham, Genglin Jin, Julia Lailai Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2011
Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumorsStephen T Keir, Mark W Dewhirst, John P Kirkpatrick, et al.
Pageof 25